Literature DB >> 29794213

Adherence in Asthma and COPD: New Strategies for an Old Problem.

Maureen George1.   

Abstract

Adherence broadly encompasses the decisions patients make as to whether health care advice should be initiated, as well as the degree to which the recommended health behaviors, once started, are maintained. Disease-related conditions such as severity and duration of illness, as well as treatment-related features such as frequency of dosing and side effects, are 2 of several factors that influence adherence. Other factors affecting adherence include socioeconomic status, patient-related causes, and health system-related reasons. Adherence is rarely, if ever, an all-or-none phenomenon. Typically, patients follow some recommendations closely while deciding others are optional; these decisions are often made without consulting with or notifying health care professionals. Non-adherence can be categorized as either unintentional or intentional. Unintentional non-adherence is easier to remedy because it responds to patient education, simplification of treatment regimens, or the use of a reminder system. Intentional non-adherence is more complex and challenging to address because patients exhibiting these behaviors often do not find evidence-based recommendations compelling, lack the motivation to follow advice, or have deeply entrenched personal beliefs that conflict with health guidance. Novel psychotherapeutic behavioral interventions, such as shared decision-making, motivational interviewing, and coaching are some approaches being tested to determine their effectiveness in mitigating the resistance to treatment that characterizes intentional non-adherence in asthma and COPD populations. In this narrative review, the extent of non-adherence to asthma and COPD management recommendations is explored, the factors affecting adherence are explicated, the methods used to measure adherence are compared and contrasted, and the effectiveness of strategies targeting unintentional and intentional non-adherence is detailed.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  COPD; adherence; asthma; behavioral interventions; coaching; motivational interviewing; navigator; shared decision-making; smart inhalers

Mesh:

Year:  2018        PMID: 29794213     DOI: 10.4187/respcare.05905

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  23 in total

1.  Lay Health Coaching to Increase Appropriate Inhaler Use in COPD: A Randomized Controlled Trial.

Authors:  Rachel Willard-Grace; Chris Chirinos; Jessica Wolf; Denise DeVore; Beatrice Huang; Danielle Hessler; Stephanie Tsao; George Su; David H Thom
Journal:  Ann Fam Med       Date:  2020-01       Impact factor: 5.166

2.  Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient- Powered Registry Network.

Authors:  Cara B Pasquale; Radmila Choate; Gretchen McCreary; Richard A Mularski; William Clark; MaryEllen Houlihan; Elisha Malanga; Barbara P Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

Review 3.  Uncontrolled Asthma: Unmet Needs in the Management of Patients.

Authors:  Marco Caminati; Rachele Vaia; Fabiana Furci; Gabriella Guarnieri; Gianenrico Senna
Journal:  J Asthma Allergy       Date:  2021-05-03

4.  Application of Once-Monthly Self-Reported ACT Questionnaire in Management of Adherence to Inhalers in Outpatients with Asthma.

Authors:  Jing Zhang; Chengchen Yin; Hongfang Li; Weipeng Wei; Yuansha Gong; Fushan Tang
Journal:  Patient Prefer Adherence       Date:  2020-06-19       Impact factor: 2.711

5.  Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.

Authors:  Gary T Ferguson; Nicola Brown; Chris Compton; Thomas C Corbridge; Kelly Dorais; Charles Fogarty; Catherine Harvey; Morrys C Kaisermann; David A Lipson; Neil Martin; Frank Sciurba; Marjorie Stiegler; Chang-Qing Zhu; David Bernstein
Journal:  Respir Res       Date:  2020-05-29

6.  Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.

Authors:  Marc Miravitlles; Alicia Marín; Alicia Huerta; David Carcedo; Alba Villacampa; Jaume Puig-Junoy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-10

7.  Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD).

Authors:  Magdalena Humenberger; Andreas Horner; Anna Labek; Bernhard Kaiser; Rupert Frechinger; Constanze Brock; Petra Lichtenberger; Bernd Lamprecht
Journal:  BMC Pulm Med       Date:  2018-10-19       Impact factor: 3.317

Review 8.  Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD.

Authors:  James F Donohue; Donald A Mahler; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-19

9.  Effect of an Educational Program on Healthcare Professionals' Readiness to Support Patients with Asthma, Allergies, and Chronic Obstructive Lung Disease for Improved Medication Adherence.

Authors:  Malin Axelsson; Benita Björk; Ulrika Berg; Karin Persson
Journal:  Nurs Res Pract       Date:  2020-10-27

10.  Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Authors:  F Maltais; I P Naya; C F Vogelmeier; I H Boucot; P W Jones; L Bjermer; L Tombs; C Compton; D A Lipson; E M Kerwin
Journal:  Respir Res       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.